Seaport Therapeutics, Inc. Share Price

Seaport Therapeutics, Inc. Share Price

NASDAQ: SPTX
$19.62
-$1.37 (-6.53%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Seaport Therapeutics, Inc. Stock Performance

Open
$21.00
Prev. Close
$20.99
Circuit Range
N/A
Day Range
$19.05 - $21.00
Year Range
$14.94 - $28.16
Volume
41,675
Average Traded
$19.58

Seaport Therapeutics, Inc. Share Price Today

As of 1 November 2026, Seaport Therapeutics, Inc.'s share price is $19.62. The stock opened at $21.00, compared to its previous close of $20.99. During today's trading session, Seaport Therapeutics, Inc.'s share price traded between $19.05 and $21.00, with an average price of $20.02. Over the past 52 weeks, the stock has recorded a high of $28.16 and a low of $14.94. In terms of performance, Seaport Therapeutics, Inc.'s share price has risen by 8.43% over the last six months and is up 8.43% on a year-on-year basis.

Seaport Therapeutics, Inc. Share Price Chart

Line chart of the Seaport Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 19.07 to 20.46, ending at 19.62.
$19.05$21.00
L
Show Current Price
H

Seaport Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Seaport Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2026
Revenue$0.00
Net Profit-$62.60
Net Profit MarginN/A
Income ChangeN/A

About Seaport Therapeutics, Inc.

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Seaport Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$19.55
$19.67
-3.25%
Sep 2026
$23.59
$20.33
-23.17%
Aug 2026
$20.00
$26.46
+29.67%
Jul 2026
$21.57
$20.41
-5.92%
Jun 2026
$18.33
$21.69
+19.87%
May 2026
$21.08
$18.09
N/A

SPTX Share Price FAQs